Fontana, Pierre

 
Title Year Hits Downloads
Evaluation of recombinant factor VIIa, tranexamic acid and desmopressin to reduce prasugrel-related bleeding: A randomised, placebo-controlled study in a rabbit model 2018 97 4
Management of antiplatelet therapy in patients undergoing elective invasive procedures: Proposals from the French Working Group on perioperative hemostasis (GIHP) and the French Study Group on thrombosis and hemostasis (GFHT 2018 76 2
[Angiology and haemostasis. Highlights on some new data in 2017] 2018 6 0
Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active Metabolites 2018 22 3
Subthalamic nucleus deep brain stimulation for Parkinson's disease in a patient with severe haemophilia A. 2017 82 0
Impact of rivaroxaban on point-of-care assays 2017 102 0
TiN x O y coatings facilitate the initial adhesion of osteoblasts to create a suitable environment for their proliferation and the recruitment of endothelial cells 2017 121 2
Platelets in liver regeneration 2017 85 3
Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) - September 2015 2017 125 0
Comparative Long-Term Effect of Three Anti-P2Y12 Drugs after Percutaneous Angioplasty: An Observational Study Based on Electronic Drug Adherence Monitoring 2017 92 10
Pannexin- and Connexin-Mediated Intercellular Communication in Platelet Function 2017 118 46
Impact of pneumatic tube system transport for the monitoring of heparin therapy 2017 74 0
Pannexin1 Single Nucleotide Polymorphism and Platelet Reactivity in a Cohort of Cardiovascular Patients 2017 134 1
Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients? 2017 85 0
Impact of a product-specific reference standard for the measurement of a PEGylated rFVIII activity: the Swiss Multicentre Field Study 2017 72 0
Platelet reactivity in stable cardiovascular patients with chronic kidney disease 2017 123 0
A multicenter study to assess the reproducibility of antiphospholipid antibody results produced by an automated system 2017 129 3
Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels 2017 75 0
Le défi des maladies vasculaires rares : l’union fait la force ! 2017 7 1
Angiologie et hémostase 2017 83 35
Thromboses veineuses splanchniques 2017 8 0
Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation 2017 89 0
News in angiology and hemostasis 2016 221 78
Modulation of osteoblast behavior on TiNxOy coatings by altering the N/O stoichiometry while maintaining a high thrombogenic potential 2016 190 3
Correction of prasugrel-related bleeding by prophylactic transfusion of human platelets in a rabbit model 2016 115 2
Vascular risk levels affect the predictive value of platelet reactivity for the occurrence of MACE in patients on clopidogrel. Systematic review and meta-analysis of individual patient data 2016 176 2
Effect of long-term adherence to clopidogrel on the VASP-PRI after elective coronary stent implantation: a randomized controlled study 2016 122 0
New molecular insights into modulation of platelet reactivity in aspirin-treated patients using a network-based approach 2016 260 6
Genetic testing to identify women at risk of venous thromboembolism with contraceptive pills: Evidence or hope-based tool ? 2016 176 60
Direct oral anticoagulants: a guide for daily practice 2016 326 141
Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect 2016 92 31
Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach 2016 181 111
La maladie thromboembolique veineuse : une pathologie souvent oubliée 2016 57 16
Pharmacogenomics of Oral Antithrombotic Drugs 2016 236 0
Genetics of clopidogrel poor-response 2016 147 0
Anticoagulants oraux directs (ACOD) : une aide à la prescription dans la pratique quotidienne 2016 72 18
Aspirin response: Differences in serum thromboxane B2 levels between clinical studies 2016 260 1
PPM1A Methylation Is Associated With Vascular Recurrence in Aspirin-Treated Patients 2016 124 0
Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis 2016 300 136
TRAF3 Epigenetic Regulation Is Associated With Vascular Recurrence in Patients With Ischemic Stroke 2016 122 0
Evidence-Based Choice of P2Y12 Inhibitors in End Stage Renal Disease Patients: A Mini-Review 2015 247 4
The Human Diabetes Proteome Project (HDPP): The 2014 update 2015 149 76
Functional role of a polymorphism in the Pannexin1 gene in collagen-induced platelet aggregation 2015 184 8
Direct oral anticoagulants: efficacy and safety in patient subgroups 2015 316 176
Impact of non-inhibited platelet supplementation on platelet reactivity in patients treated with prasugrel or ticagrelor for an acute coronary syndrome: An ex vivo study 2015 209 0
Lack of Effect of Platelet Transfusions and Desmopressin on Intracranial Bleeding in a Patient Receiving Ticagrelor 2015 193 1
Reply to: "The role of platelets in liver regeneration - What don't we know?" 2015 115 0
Large external quality assessment survey on thrombin generation with CAT: further evidence for the usefulness of normalisation with an external reference plasma 2015 143 97
Fibrin degradation during sonothrombolysis – Effect of ultrasound, microbubbles and tissue plasminogen activator 2015 223 0
Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants 2015 164 99
Suspicion of heparin-induced thrombocytopenia in internal medicine: How appropriate is the ordering of anti-PF4/heparin antibody testing? 2015 243 2
Antiplatelet drugs and platelet reactivity: is it time to halt clinical research on tailored strategies? 2015 286 1
Laboratory testing of Hemostasis 2015 84 70
Characterisation of the influences of aspirin-acetylation and glycation on human plasma proteins 2015 298 1
A focus on the role of platelets in liver regeneration: do platelet-endothelial cell interactions initiate the regenerative process? 2015 256 0
Aspirin-mediated acetylation of haemoglobin increases in presence of high glucose concentration and decreases protein glycation 2015 108 72
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 2014 271 1
Impact of high glucose concentration on aspirin-induced acetylation of human serum albumin: An in vitro study 2014 106 30
Evaluation of the GEM®PCL Plus point-of-care device for neonatal coagulation assessment: An observational study on cord blood 2014 191 2
Fibrinogen geneva II: a new congenitally abnormal fibrinogen alpha chain (Gly17Asp) with a review of similar mutations resulting in abnormal knob A. 2014 257 3
Direct oral anticoagulants in the treatment and long-term prevention of venous thrombo-embolism 2014 248 128
Antiplatelet Therapy: Targeting the TxA2 Pathway 2014 234 2
Role of paraoxonase-1 in CYP2C19 loss-of-function carriers 2014 259 0
Characterization of the platelet granule proteome: Evidence of the presence of MHC1 in alpha-granules 2014 358 3
Hémostase. Aspirine: une ou deux fois par jour? 2014 287 2
How to manage prasugrel and ticagrelor in daily practice 2014 116 90
Refinement of the cutoff values of the HemosIL AcuStar assay for the detection of anticardiolipin and anti-beta2 glycoprotein-1 antibodies 2014 233 0
Sputtered titanium oxynitride coatings for endosseous applications: Physical and chemical evaluation and first bioactivity assays 2014 341 1
Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the Working Group on Perioperative Haemostasis (GIHP) - March 2013 2013 190 0
Thrombotic complications of myeloproliferative neoplasms: risk assessment and risk-guided management 2013 249 0
Unraveling modulators of platelet reactivity incardiovascular patients using omics strategies: Towards anetwork biology paradigm 2013 263 222
Gestion péri-interventionnelle des nouveaux agents antiplaquettaires 2013 263 140
Tailored Thienopyridine therapy: no urgency for CYP2C19 genotyping 2013 165 0
Hémostase : nouveaux anticoagulants oraux : de la théorie à la pratique 2013 95 0
The Human Diabetes Proteome Project (HDPP): From network biology to targets for therapies and prevention 2013 250 17
Antiplaquettaires et patients âgés : quelles molécules et quelles preuves ? 2013 233 1
Gestes invasifs et patients sous anticoagulants oraux : to bridge or not to bridge ? 2013 249 1
Aspirin for venous thromboembolism prevention and treatment: a renewal? 2012 234 99
The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro 2012 194 0
Platelet proteomics 2012 224 2
Prevalence of poor biological response to clopidogrel: a systematic review 2012 178 0
Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis 2012 238 0
Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events study 2012 281 3
Poor responsiveness to antiplatelet drugs in acute coronary syndromes: clinical relevance and management 2012 247 0
The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin 2011 227 0
Relationship between paraoxonase-1 activity, its Q192R genetic variant and clopidogrel responsiveness in the ADRIE study 2011 241 0
Connexin 37 limits thrombus propensity by downregulating platelet reactivity 2011 305 400
Surveillance biologique des héparines et du fondaparinux 2011 244 2
Platelet reactivity is a stable and global phenomenon in aspirin-treated cardiovascular patients 2011 266 1
Antiagregants plaquettaires : lequel, quand et pour qui ? 2010 211 0
Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE study 2010 232 0
Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysis 2010 172 0
Evaluation de l'efficacité biologique du clopidogrel: génotype ou phénotype? 2010 188 0
Maladies cardiovasculaires, antiagrégants, anticoagulants et risque hémorragique 2010 247 0
Hémostase. Le point sur les nouveaux antithrombotiques 2010 233 0
Impact of genetic polymorphisms and drug-drug interactions on clopidogrel and prasugrel response variability 2010 270 0
Platelet hyperreactivity and dual antiplatelet therapy: can biases be avoided? 2009 209 0
Intercellular communication in atherosclerosis 2009 242 0
No influence of the VAMP8 rs1010 single nucleotide polymorphism on platelet functions in vitro 2009 214 0
Diagnosis of mild bleeding disorders 2009 283 924
Cell-derived microparticles in haemostasis and vascular medicine 2009 220 0
Acute coronary syndrome and its antithrombotic treatment: focus on aspirin and clopidogrel resistance 2009 175 0
Le concept de "resistance" a l'aspirine: mecanismes et pertinence clinique 2009 230 0
Assessing aspirin responsiveness using the Verify Now Aspirin assay 2008 258 1
Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis 2008 264 1
Laboratory-defined aspirin resistance and recurrent cardiovascular events 2008 234 0
Aspirin "resistance" and risk of cardiovascular morbidity 2008 206 1
Aspirin response variability assessed with the PFA-100 device 2008 245 0
Impending paradoxical embolism. When and how to treat? 2008 250 1
Biological effect of increased maintenance dose of clopidogrel in cardiovascular outpatients and influence of the cytochrome P450 2C19*2 allele on clopidogrel responsiveness 2008 218 0
20738 3400